PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'London School of Economics & Political Science, United Kingdom.\', \'Stanford University School of Medicine, United States.\', \'Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands; Ministry of Health, Welfare and Sport, The Hague, the Netherlands.\', \'London School of Hygiene & Tropical Medicine, United Kingdom.\', \'London School of Economics & Political Science, United Kingdom; Imperial College London, United Kingdom. Electronic address: e.a.mossialos@lse.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0168-8510(21)00085-310.1016/j.healthpol.2021.03.013
?:hasPublicationType
?:journal
  • Health policy (Amsterdam, Netherlands)
is ?:pmid of
?:pmid
?:pmid
  • 33820678
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all